Psychiatric units safer as in-patient suicide falls
Suicides by psychiatric in-patients have fallen to a new low, research published today has found.
May 16, 2012
Archive: 16/05/2012
Pancreatic islets infusion for diabetes patient being readied for procedure in Japan
The Japanese Pancreas and Islet Transplantation Association (JPITA) is preparing for the nation's first transplantation of pancreatic islets from a brain-dead donor to a patient with Type 1 diabetes, it was learned Saturday.
May 16, 2012
Raising HDL not a sure route to countering heart disease
A new paper published online in The Lancet challenges the assumption that raising a person's HDL — the so-called "good cholesterol" — will necessarily lower the risk of a heart attack. The new research underscores ...
May 16, 2012
Hormone-depleting drug shows promise against localized high-risk prostate tumors
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, ...
May 16, 2012
Experimental agent may help older people with chronic leukemia
The experimental drug ibrutinib (PCI-32765) shows great promise for the treatment of elderly patients with chronic lymphocytic leukemia (CLL), according to interim findings from a clinical trial.
May 16, 2012
Phase I study of temsirolimus, capecitabine proves safe; positive survival trend seen
A phase I clinical trial examining the safety of combining temsirolimus and capecitabine in advanced malignancies suggests the two agents can be given safely to patients. In addition, the Georgetown Lombardi Comprehensive ...
May 16, 2012
Revised glioblastoma classification should improve patient care
Radiation oncology researchers have revised the system used by doctors since the 1990s to determine the prognosis of people with glioblastoma, which is the most devastating of malignant brain tumors.
May 16, 2012
Study combines lapatinib with cetuximab to overcome resistance in EGFR-driven tumors
Targeted therapies have been studied for years, but recent laboratory research is providing robust clues about drugs that might work better in combination, particularly in treating cancers that have become resistant to therapy. ...
May 16, 2012
